Skip to content

    Recently Viewed


      Headshots of tuberculosis survivors Manasi Khade and Gerry Elsdon on a pink world map background

      “We weren’t supposed to get tuberculosis": Meet two surprising survivors who could be you

      A 20-something photographer. A famous TV personality. They share one thing in common that you’d never expect—both have triumphed over tuberculosis. For World TB Day, we share their inspiring stories.

      Share Article
      share to

      An estimated 10 million people are infected with active tuberculosis (TB) each year, and around 1.6 million die from the disease, making it one of the world’s greatest health threats.

      And as you’ll see from these moving stories, the disease doesn’t discriminate either.

      “It’s time for people to be more aware of tuberculosis,” says Cat Oyler, Vice President, Global Public Health, Johnson & Johnson. “It’s time for patients to be heard, to remove the stigma associated with TB—and for us all to commit to continue innovating in the fight against TB. This is a winnable battle. It is time to end this disease now.”

      For its part, Johnson & Johnson has long been committed to helping end the disease through innovation, which is why the company recently announced a comprehensive 10-year commitment in support of global efforts to end TB by 2030 by improving access to treatment, accelerating how patients are identified, and advancing research and development efforts to create tomorrow’s TB treatment regimens.

      Also essential in making strides to end TB: awareness.

      That’s why, for World TB Day—this year’s apt theme is “It’s time”—we’re sharing these moving personal stories of triumph over TB.

      TB survivor Manasi Khade

      Manasi Khade, 24, Mumbai, India

      “I was a completely normal college kid living a normal life, with normal routines,” says Manasi Khade, an advertising professional and photographer in Mumbai.

      But at 19, she was diagnosed with extensively drug-resistant TB (XDR-TB), a form of the disease that is resistant to at least four of the major anti-TB drugs.

      “I was at a point in my life where I was beginning to pursue my dreams, but after going to the doctor for a routine thyroid test, I was diagnosed with TB,” she says. When the doctor told her she had just six months to live, she “was heartbroken, and felt everything in my life was slipping away.”

      India has the highest burden of TB in the world, and Khade had seen the devastating effects of the disease on her grandfather, one of her uncles and her father. “I didn’t want my family to struggle even more because of me, so I tried not to show my pain. But people stopped coming to our house because I had TB, and they didn’t understand that it wasn’t my fault. I got very depressed.”

      Watching her father, who lost his eyesight to TB, ultimately triumph over the disease is what finally lifted Khade’s spirits and gave her the courage to fight through 2 1/2 years of treatment and surgery to remove part of her right lung.

      Today she is cured—and living life to the fullest, having completed a multiday bike trek from Mumbai to Leh Ladakh, something she’d always dreamed of.

      Now her wish is to see the day when TB doesn’t exist anymore—and she knows she has an integral part to play through advocacy.

      “I don’t want this to happen to future generations,” she says. “It’s very important, especially for women, to end the stigma surrounding TB. In India, particularly in rural areas, females receive less emotional support from family and friends, and have less access to nutrition and health services. We need to speak up.”

      One unintended side effect of Khade’s experience with TB is that it changed the way she views her photography.

      “It’s hard to describe, and people may think it’s weird, but everything I see, and everything my camera sees, is a miracle. The fact that I survived was a miracle, so what I am seeing in every photograph is a miracle to me.”
      TB survivor Gerry Elsdon

      Gerry Elsdon, 47, Johannesburg, South Africa

      In 2001, Gerry Elsdon went to her doctor for a fertility test and got results she never expected: The South African media personality and TV presenter was diagnosed with TB in her womb.

      “I’d never known anyone who’d had TB, and I’d never heard of anyone who had TB anywhere other than their lungs,” Elsdon recalls.

      She immediately started taking medication, and during her nine months of treatment, Elsdon did not experience any of the typical symptoms of the disease. “My lungs didn’t hurt, and I had none of the coughing,” she says. “Being non-symptomatic almost made it more difficult. I kept thinking: Why am I doing this? Why am I swallowing seven pills a day when there’s nothing wrong with me?”

      But persistence with her treatment paid off. “I was cured,” she says, “but unfortunately, my womb was no longer viable. I couldn’t have kids. And I think that’s one of the reasons I decided to speak out about this scourge.”

      Today, in her role as TB ambassador for the National Department of Health in South Africa and TB champion for the World Health Organization in Geneva, Elsdon works to raise awareness about issues surrounding TB that remain taboo in South Africa and developing nations around the world.

      For example, people with HIV in Elsdon’s home country often die from TB, due to their lowered immune systems. So people who do not have HIV are afraid to seek treatment for TB for fear that others might think they’re HIV-positive.

      “People aren’t going in for treatment because of that stigma,” Elsdon says. “That’s why we need to make the TB discussion as common as ones about the common cold. TB knows no boundaries. It doesn’t choose white or black, rich or poor, American or African. Everyone needs to speak up.

      Johnson & Johnson’s Quest to End TB

      Read about how the company is working to improve detection, broaden access to treatment, and accelerate research and development for the disease over the next decade.

      More from Johnson & Johnson

      Blue latex-gloved hands holding a beaker filled with yellow liquid

      IBD rates are rising in communities of color. Can these innovators help?

      Scientists aren’t sure what’s behind the upward trend. That’s why Johnson & Johnson Innovation put out the call to address this troubling health disparity.
      DNA illustration genetic material

      Harnessing the human genome is the future of healthcare—and Johnson & Johnson is helping lead the way

      The company’s partnership with the largest human genome sequencing project in the world will increase scientists’ understanding of genetic diseases and help create new interventions. Here, a look at the breakthroughs that have guided the understanding of the power of DNA.
      Health & wellness
      1123 BTN-Lung Cancer-Iede2.jpg
      Health & wellness

      By the numbers: Who gets lung cancer?

      Each year, more people die of lung cancer than colon, breast and prostate cancers combined. Learn how Johnson & Johnson is dedicated to improving outcomes by integrating the company’s MedTech and Innovative Medicine expertise.
      You are now leaving and going to a site with a different privacy policy. Please click below to continue to that site.